United States

Back to map

Showing 261-270 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Bioactive Granular Hydrogels for Islet Delivery Regents of the University of Michigan Maria Coronel Cures 01-September-2022 to 31-August-2025 $400.000,00
A Multi-task Learning Framework for Developing Genetic Risk Score (GRS) Models of T1D for Multi-Ethnic Population University of Washington Shuai Huang Cures 01-August-2022 to 31-August-2025 $300.081,37
Improving prediction of T1D risk by establishing a self-administered CGM-based technology and whole genome-based polygenic risk scores in diverse populations Rector & Visitors of the University of Virginia Leon Farhy Cures 01-August-2022 to 31-July-2025 $599.999,66
Clinical and Economic Optimization Platform for Type 1 Diabetes Screening Regents of the University of Colorado R. Brett McQueen Cures 01-September-2022 to 31-August-2024 $483.523,62
Phenotyping RElatives of persons with Diabetes with CGM and Tests of beta-cell function and health (PREDICT): an integrated longitudinal assessment of deep metabolic phenotyping and CGM metrics in youth at risk for T1D Yale University Alfonso Galderisi Cures 01-February-2023 to 31-January-2026 $747.380,88
PREdictors for DiabetIC Ketoacidosis at Diagnosis of Type 1 Diabetes (The PREDICT study) Rutgers, The State University of New Jersey Chintan Dave Cures 01-August-2022 to 31-July-2025 $695.404,04
Novel Combination Regimen Therapy to Modulate Pro- and Anti-inflammatory Lipid Signaling to Counter T1D The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham Sasanka Ramanadham Cures 01-July-2022 to 30-June-2025 $600.000,00
Combination of anti-CD3 mAb and antigen specific nanoparticles for prevention and treatment of Type 1 diabetes Yale University Kevan Herold Cures 01-June-2022 to 30-April-2025 $600.000,00
Restoration of Treg function to prevent progression to hyperglycemia Stanford University C. Garrison Fathman Cures 01-June-2022 to 31-May-2025 $600.000,00
Targeting type 1 Diabetes through Polyamines with DFMO Trustees of Indiana University Emily Sims Cures 01-October-2022 to 30-September-2026 $3.693.701,00